These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients. van der Klaauw AA; Pereira AM; van Thiel SW; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA Clin Endocrinol (Oxf); 2007 Apr; 66(4):489-98. PubMed ID: 17371464 [TBL] [Abstract][Full Text] [Related]
24. Acromegaly, diabetes insipidus, and visual loss caused by metastatic growth hormone-releasing hormone-producing malignant pancreatic endocrine tumor in the pituitary gland. Case report. Genka S; Soeda H; Takahashi M; Katakami H; Sanno N; Osamura Y; Fuchinoue T; Teramoto A J Neurosurg; 1995 Oct; 83(4):719-23. PubMed ID: 7674023 [TBL] [Abstract][Full Text] [Related]
25. Prostatic disorders in acromegalic patients experience of a Brazilian center. CorrĂȘa LL; Balarini Lima GA; Cavallieri SA; Miranda LC; Gadelha MR Int Braz J Urol; 2013; 39(3):393-401. PubMed ID: 23849571 [TBL] [Abstract][Full Text] [Related]
26. Nocturnal monitoring of growth hormone, insulin, C-peptide, and glucose in patients with acromegaly. Tsai JS; Zorrilla LL; Jacob KK; Rosenberg S; Marcus DL Am J Med Sci; 1996 Jun; 311(6):281-5. PubMed ID: 8659555 [TBL] [Abstract][Full Text] [Related]
27. Induction of growth hormone and prolactin secretion by luteinizing hormone-releasing hormone and its blockade by bromoergocriptine in acromegalic patients. Ishibashi M; Yamaji T; Kosaka K J Clin Endocrinol Metab; 1978 Aug; 47(2):418-21. PubMed ID: 400720 [TBL] [Abstract][Full Text] [Related]
28. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Resmini E; Minuto F; Colao A; Ferone D Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513 [TBL] [Abstract][Full Text] [Related]
29. Prolactin secretion abnormalities in patients with the "syndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex). Raff SB; Carney JA; Krugman D; Doppman JL; Stratakis CA J Pediatr Endocrinol Metab; 2000 Apr; 13(4):373-9. PubMed ID: 10776991 [TBL] [Abstract][Full Text] [Related]
31. A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13. Stock JL; Warth MR; Teh BT; Coderre JA; Overdorf JH; Baumann G; Hintz RL; Hartman ML; Seizinger BR; Larsson C; Aronin N J Clin Endocrinol Metab; 1997 Feb; 82(2):486-92. PubMed ID: 9024241 [TBL] [Abstract][Full Text] [Related]
32. Two cases of acromegaly in a family. Kakiya S; Kawakubo A; Toyama K; Yamamoto M Endocr J; 1997 Apr; 44(2):227-31. PubMed ID: 9228457 [TBL] [Abstract][Full Text] [Related]
33. Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance. Silha JV; Krsek M; Hana V; Marek J; Jezkova J; Weiss V; Murphy LJ Clin Endocrinol (Oxf); 2003 Jun; 58(6):736-42. PubMed ID: 12780751 [TBL] [Abstract][Full Text] [Related]
34. Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Kasayama S; Otsuki M; Takagi M; Saito H; Sumitani S; Kouhara H; Koga M; Saitoh Y; Ohnishi T; Arita N Clin Endocrinol (Oxf); 2000 May; 52(5):549-55. PubMed ID: 10792333 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of serum IGF-I and IGFBP-3 in growth hormone disorders in adults. Kim HJ; Kwon SH; Kim SW; Park DJ; Shin CS; Park KS; Kim SY; Cho BY; Lee HK Horm Res; 2001; 56(3-4):117-23. PubMed ID: 11847474 [TBL] [Abstract][Full Text] [Related]
36. Grwoth hormone, prolactin, and cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate. Concannon P; Altszuler N; Hampshire J; Butler WR; Hansel W Endocrinology; 1980 Apr; 106(4):1173-7. PubMed ID: 6444575 [TBL] [Abstract][Full Text] [Related]
38. Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumor. Ezzat S; Ezrin C; Yamashita S; Melmed S Cancer; 1993 Jan; 71(1):66-70. PubMed ID: 8416728 [TBL] [Abstract][Full Text] [Related]
39. Dynamic testing in the diagnosis and follow-up of patients with acromegaly. Wass JA J Endocrinol Invest; 2003; 26(7 Suppl):48-53. PubMed ID: 14604066 [TBL] [Abstract][Full Text] [Related]
40. Lack of effect of thyroid hormones on the growth hormone response to thyrotropin-releasing hormone in acromegaly. Carlson HE; Sowers JR; Rand RW Metabolism; 1977 Jul; 26(7):801-5. PubMed ID: 405552 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]